Newsroom

PARIS--(BUSINESS WIRE)--  TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces, as of today, December 8, 2025, the commencement of trading of its ordinary shares on the New York Stock Exchange (“NYSE”), replacing the listing of its American Depositary Receipts (“ADRs”). These ordinary shares trade under the same ticker symbol “TTE” as the one on Euronext and as the former ADR ticker. On October 30, 2025, the Company had announced the termination of its American Depositary Receipts (“ADRs...

PARIS--(BUSINESS WIRE)--Regulatory News: TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) annonce à compter de ce jour, 8 décembre 2025, le début de la cotation de ses actions ordinaires sur le New York Stock Exchange (« NYSE ») en remplacement de la cotation de ses American Depositary Receipts (« ADR »). Ces actions ordinaires sont négociées sous le même ticker « TTE » que celui sur Euronext et que l’ancien ticker des ADR. Le 30 octobre 2025, la Société avait annoncé la résiliation de son pro...

PARIS--(BUSINESS WIRE)--Regulatory News: TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces, as of today, December 8, 2025, the commencement of trading of its ordinary shares on the New York Stock Exchange (“NYSE”), replacing the listing of its American Depositary Receipts (“ADRs”). These ordinary shares trade under the same ticker symbol “TTE” as the one on Euronext and as the former ADR ticker. On October 30, 2025, the Company had announced the termination of its American Depositary...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 05.12.2025 GMAY.LN IE000P0FL8E3 1,000,002.00 USD  38,109,281.90   38.109  ...

TÜBINGEN, Deutschland--(BUSINESS WIRE)--Nur wenige Monate nach der weltweit ersten gastrischen Mukosaablation (GMA) mit MOVIVA® am Policlinico Universitario Agostino Gemelli in Rom verbreitet sich dieses klinische Verfahren rasch in ganz Europa. Mit rund 80 Eingriffen innerhalb kürzester Zeit in acht Ländern leitet MOVIVA® angesichts des andauernden weltweiten Anstiegs der Adipositas Erkrankungen mit einer minimalinvasiven Option eine neue Ära der endoskopischen bariatrischen Behandlung ein. Ei...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 05.12.2025 FTMO.LN IE000CY30YV9 2,950,002.00 USD  73,516,099.53   24.921  ...

SAN CARLOS, California--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), un’azienda operante nel settore oncologico a livello globale, oggi ha annunciato che alla 67esima edizione del Congresso Annuale della American Society of Hematology (ASH) tenutosi a Orlando, Florida sono stati presentati nuovi dati su sonrotoclax, un inibitore BCL2 di nuova generazione in fase di sperimentazione, che mostrano un significativo beneficio clinico sia in monoterapia sia in combin...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.12.2025 SDVI.LN IE000YVOQ2A3   40,361.00 USD   1,055,069.22   26.141  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 05.12.2025 SDVY.LN IE0001R850E1 10,879,007.00 USD 249,426,820.94   22.927  ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een internationaal oncologiebedrijf, maakte vandaag nieuwe gegevens bekend over sonrotoclax, een onderzoeks-BCL2-remmer van de nieuwe generatie, die belangrijk klinisch voordeel aantoonden als monotherapie en in combinatie bij behandeling van B-cel maligniteiten. Deze gegevens werden voorgesteld tijdens de 67e Annual Meeting & Exposition van de ASH (American Society of Hematology) in Orlando,...